HealPros and BioIQ Collaborate to Deliver a Comprehensive Diabetes Care Gap Closure Solution to Help Health Plans Improve Quality Ratings

Posted Aug 16, 2017

ATLANTA -- (BUSINESS WIRE) -- HealPros, a technology-enabled company providing HEDIS and STAR improvement programs, and BioIQ, a technology platform driving the employer and health plan shift to value-based care, have partnered to provide a comprehensive diabetes care gap closure solution to help health plans improve quality ratings for Comprehensive Diabetes Care (CDC) HEDIS measures. Proper diabetes management is essential to control blood glucose, reduce risks for complications and improve health outcomes. The joint offering will combine HealPros’ Diabetic Retinal Eye (DRE) exams with BioIQ’s convenient at-home health test kits and technology solutions.

Together, HealPros and BioIQ will offer health plans a scalable, effective, solution that helps them meet requirements for all three CDC measures – retinopathy screening, HbA1c testing and HbA1c glucose control, and kidney disease screening – all from the comfort of their members’ own home in a single encounter. HealPros provides member outreach along with trained technologists to deliver services in the home setting.

This solution will enable health plans to address not only the DRE care measure, but additional measures using at-home test kits, including colorectal cancer screening. This allows health plans to meet HEDIS requirements while maximizing the effectiveness of at-home screening initiatives and providing a seamless member experience.

Mike Yom, Chief Product Officer at HealPros, said, “HealPros’ innovative process for managing mobile care is the perfect modality for scaling BioIQ’s technology and health testing programs. This combined offering gives health plans an opportunity to engage hard-to-reach populations and improve quality ratings, while delivering better service and greater convenience to their members.”

Joshua Sclar, MD, MPH, Chief Medical Officer at BioIQ, said, “BioIQ is committed to making high-value preventive health services more accessible and easier for people to use. Combining our innovative diabetes testing and measurement capabilities with the leading provider of in-home diabetic retinal exams allows us to offer our customers best-in-class, comprehensive, consumer-friendly care for people with diabetes.”

BioIQ makes it easy to orchestrate large-scale member outreach and health testing programs to help health plans close care gaps for comprehensive diabetes care (CDC) and other measures. To learn more, contact BioIQ at (888) 818-1594 or sales@bioiq.com.

About HealPros

Founded in 2011, HealPros provides mobile diabetic retinopathy examinations on behalf of healthcare payers across the country. HealPros is able to reach payer clients' members who are not regularly meeting with primary care physicians or eye care professionals to perform essential examinations. HealPros provides mobile diabetic eye examinations in member's homes, at primary care practices, in multi-specialty health centers, and other venues as designated by payer clients.

About BioIQ

BioIQ simplifies health testing for health plans and enterprises of all sizes and empowers people to take action to improve their health. The BioIQ Platform provides tools for orchestrating health testing programs and biometric screening events across multiple vendors, as well as multi-channel communication tools for engaging and motivating participants at every step of the way. BioIQ also provides a means to intervene when risks for chronic conditions are found – with a unified solution for keeping at-risk populations up-to-date with health testing, along with data analysis for managing risks and resources to help people live their healthiest lives. Since 2005, BioIQ has launched thousands of successful health testing programs serving millions of participants.

To view the original version on BusinessWire, visit: http://www.businesswire.com/news/home/20170815005404/en/HealPros-BioIQ-Collaborate-Deliver-Comprehensive-Diabetes-Care


0 Comments